The global drug discovery services market is valued at $22.04 billion in 2025 and is forecast to reach $75.13 billion by 2034, growing at a 14.6% CAGR from 2026-2034, driven by rising industry demand and technological advancements.
Anbio Biotechnology shares gained following an upgrade from a sell rating to hold. The company reported $0.04 earnings per share and $2.29 million in quarterly revenue.
Johnson & Johnson announced plans to invest more than $1 billion in a next-generation cell therapy manufacturing facility in Montgomery County, Pennsylvania, creating over 500 biomanufacturing jobs and 4,000 construction positions as part of its $55 billion U.S. investment commitment.
Moderna faces a pivotal transition from pandemic-era revenues to a diversified mRNA portfolio, with recent regulatory setbacks offset by strong RSV vaccine performance and upcoming Phase 3 oncology readouts.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07090200 |
Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases |
RECRUITING | NA |
| NCT06931782 |
AI in Respiratory Disease Prevention, Diagnosis, and Triage |
ENROLLING_BY_INVITATION | NA |
| NCT06479785 |
Effects of an Educational Intervention Program on Marble Factory Workers |
COMPLETED | NA |
| NCT06454513 |
Efficacy of Different Anesthesia Methods in Transbronchial Biopsy |
COMPLETED | |
| NCT06373939 |
Performance and Safety of the Pneumoscope Device in Adults and Children |
RECRUITING | NA |
| NCT06366113 |
Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) |
RECRUITING | NA |
| NCT06267859 |
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children |
RECRUITING | EARLY_PHASE1 |
| NCT06229613 |
Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study |
COMPLETED | |
| NCT05978011 |
2014TP001 - Assessing the Biology of the Injured Lung - Version 1 |
COMPLETED | |
| NCT05175313 |
Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases |
UNKNOWN |
